BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15990867)

  • 21. Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
    Kudva GC; Chandy M; Raghupathy P; Dennison D; Srivastava A; Bhushan V; Singh R
    Indian J Cancer; 1994 Jun; 31(2):78-85. PubMed ID: 7927453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia.
    Laughton SJ; Ashton LJ; Kwan E; Norris MD; Haber M; Marshall GM
    J Clin Oncol; 2005 Apr; 23(10):2264-71. PubMed ID: 15800317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
    Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
    Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent progress in the treatment of hematological malignancies. II. Acute lymphoblastic leukemia (ALL)].
    Shirakawa S; Kita K; Kobayashi T
    Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):769-73. PubMed ID: 2794658
    [No Abstract]   [Full Text] [Related]  

  • 27. Curing children with leukemia in West Virginia.
    Ritchey AK; Starling KA; Keller FG; Martin J; Steiner ME; Defazio J
    W V Med J; 1997; 93(4):179-81. PubMed ID: 9274141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.
    Bernard OA; Busson-LeConiat M; Ballerini P; Mauchauffé M; Della Valle V; Monni R; Nguyen Khac F; Mercher T; Penard-Lacronique V; Pasturaud P; Gressin L; Heilig R; Daniel MT; Lessard M; Berger R
    Leukemia; 2001 Oct; 15(10):1495-504. PubMed ID: 11587205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
    Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
    Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
    Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
    Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.
    Tsuchida M; Ohara A; Manabe A; Kumagai M; Shimada H; Kikuchi A; Mori T; Saito M; Akiyama M; Fukushima T; Koike K; Shiobara M; Ogawa C; Kanazawa T; Noguchi Y; Oota S; Okimoto Y; Yabe H; Kajiwara M; Tomizawa D; Ko K; Sugita K; Kaneko T; Maeda M; Inukai T; Goto H; Takahashi H; Isoyama K; Hayashi Y; Hosoya R; Hanada R;
    Leukemia; 2010 Feb; 24(2):383-96. PubMed ID: 20033052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute lymphoblastic leukemia in infants.
    Gürgey A; Yetgin S; Cetin M; Gümrük F; Tuncer AM; Tunçbilek E; Hiçsönmez G
    Turk J Pediatr; 2004; 46(2):115-9. PubMed ID: 15214738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different outcome in older children with acute lymphoblastic leukemia with different treatment protocols in the Netherlands.
    Boudestein K; Kamps WA; Veerman AJ; Pieters R
    Pediatr Blood Cancer; 2012 Jan; 58(1):17-22. PubMed ID: 21254376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
    Kołecki P; Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
    [No Abstract]   [Full Text] [Related]  

  • 38. [Infectious complications of the treatment of acute lymphoblastic leukemia in children].
    Rubie H; Assouline C; Prere MF; Dutour A; Lemozy J; Mouls JL; Gayet-Mengelle C; Robert A
    Pediatrie; 1990; 45(5):333-8. PubMed ID: 2165247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    Mauger DC; Skeen JE
    N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.